Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Budimirovic, Dejan B. (14420897100)"

Filter results by typing the first few letters
Now showing 1 - 6 of 6
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders
    (2023)
    Trajković, Jelena (56018166300)
    ;
    Makevic, Vedrana (58078267500)
    ;
    Pesic, Milica (59602232000)
    ;
    Pavković-Lučić, Sofija (12243737400)
    ;
    Milojevic, Sara (58079023600)
    ;
    Cvjetkovic, Smiljana (57194632924)
    ;
    Hagerman, Randi (7006679292)
    ;
    Budimirovic, Dejan B. (14420897100)
    ;
    Protic, Dragana (18635502600)
    Fragile X syndrome (FXS) is a global neurodevelopmental disorder caused by the expansion of CGG trinucleotide repeats (≥200) in the Fragile X Messenger Ribonucleoprotein 1 (FMR1) gene. FXS is the hallmark of Fragile X-associated disorders (FXD) and the most common monogenic cause of inherited intellectual disability and autism spectrum disorder. There are several animal models used to study FXS. In the FXS model of Drosophila, the only ortholog of FMR1, dfmr1, is mutated so that its protein is missing. This model has several relevant phenotypes, including defects in the circadian output pathway, sleep problems, memory deficits in the conditioned courtship and olfactory conditioning paradigms, deficits in social interaction, and deficits in neuronal development. In addition to FXS, a model of another FXD, Fragile X-associated tremor/ataxia syndrome (FXTAS), has also been established in Drosophila. This review summarizes many years of research on FXD in Drosophila models. © 2022 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders
    (2023)
    Trajković, Jelena (56018166300)
    ;
    Makevic, Vedrana (58078267500)
    ;
    Pesic, Milica (59602232000)
    ;
    Pavković-Lučić, Sofija (12243737400)
    ;
    Milojevic, Sara (58079023600)
    ;
    Cvjetkovic, Smiljana (57194632924)
    ;
    Hagerman, Randi (7006679292)
    ;
    Budimirovic, Dejan B. (14420897100)
    ;
    Protic, Dragana (18635502600)
    Fragile X syndrome (FXS) is a global neurodevelopmental disorder caused by the expansion of CGG trinucleotide repeats (≥200) in the Fragile X Messenger Ribonucleoprotein 1 (FMR1) gene. FXS is the hallmark of Fragile X-associated disorders (FXD) and the most common monogenic cause of inherited intellectual disability and autism spectrum disorder. There are several animal models used to study FXS. In the FXS model of Drosophila, the only ortholog of FMR1, dfmr1, is mutated so that its protein is missing. This model has several relevant phenotypes, including defects in the circadian output pathway, sleep problems, memory deficits in the conditioned courtship and olfactory conditioning paradigms, deficits in social interaction, and deficits in neuronal development. In addition to FXS, a model of another FXD, Fragile X-associated tremor/ataxia syndrome (FXTAS), has also been established in Drosophila. This review summarizes many years of research on FXD in Drosophila models. © 2022 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia; [Mutacije FMR1 gena uzrokuju razvojne i degenerativne poremećaje nervnog sistema: Značaj testiranja na nestabilni X hromozom u Srbiji]
    (2016)
    Budimirovic, Dejan B. (14420897100)
    ;
    Protic, Dragana (18635502600)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Raising knowledge and awareness of fragile x syndrome in serbia, georgia, and colombia: A model for other developing countries?
    (2021)
    Protic, Dragana (18635502600)
    ;
    Salcedo-Arellano, Maria Jimena (57188928514)
    ;
    Stojkovic, Maja (57211798088)
    ;
    Saldarriaga, Wilmar (37062002500)
    ;
    Vidal, Laura Alejandra Ávila (57219650215)
    ;
    Miller, Robert M. (57191992935)
    ;
    Tabatadze, Nazi (57207796727)
    ;
    Peric, Marina (57391989400)
    ;
    Hagerman, Randi (7006679292)
    ;
    Budimirovic, Dejan B. (14420897100)
    Fragile X syndrome is the most common monogenetic cause of inherited intellectual disability and syndromic autism spectrum disorder. Fragile X syndrome is caused by an expansion (full mutation ≥200 CGGs repeats, normal 10-45 CGGs) of the fragile X mental retardation 1 (FMR1) gene, epigenetic silencing of the gene, which leads to reduction or lack of the gene’s product: the fragile X mental retardation protein. In this cross-sectional study, we assessed general and pharmacotherapy knowledge (GK and PTK) of fragile X syndrome and satisfaction with education in neurodevelopmental disorders (NDDs) among senior medical students in Serbia (N=348), Georgia (N=112), and Colombia (N=58). A self-administered 18-item questionnaire included GK (8/18) and PTK (7/18) components and self-assessment of the participants education in NDDs (3/18). Roughly 1 in 5 respondents had correct answers on half or more facts about fragile X syndrome (GK>PTK), which ranged similarly 5-7 in Serbia, 6-8 in Georgia, and 5-8 in Colombia, respectively. No cohort had an average value greater than 9 (60%) that would represent passing score “cut-off.” None of the participants answered all the questions correctly. More than two-thirds of the participants concluded that they gained inadequate knowledge of NDDs during their studies, and that their education in this field should be more intense. In conclusion, there is a major gap in knowledge regarding fragile X syndrome among senior medical students in these three developing countries. The finding could at least in part be generalized to other developing countries aimed toward increasing knowledge and awareness of NDDs and fostering an institutional collaboration between developed and developing countries. © 2021.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort
    (2022)
    Budimirovic, Dejan B. (14420897100)
    ;
    Protic, Dragana D. (18635502600)
    ;
    Delahunty, Carol M. (26026204500)
    ;
    Andrews, Howard F. (7102091416)
    ;
    Choo, Tse-Hwei (56797933200)
    ;
    Xu, Qing (57370109600)
    ;
    Berry-Kravis, Elizabeth (7003985402)
    ;
    Kaufmann, Walter E. (57216064217)
    Fragile X syndrome (FXS), the leading cause of inherited intellectual disability and autism spectrum disorder, is associated with multiple neurobehavioral abnormalities including sleep difficulties. Nonetheless, frequency, severity, and consequences of sleep problems are still unclear. The Fragile X Online Registry with Accessible Research Database (FORWARD-version-3), including Clinician Report and Parent Report forms, was analyzed for frequency, severity, relationship with behavioral problems, and impact of sleep difficulties in a mainly pediatric cohort. A focused evaluation of sleep apnea was also conducted. Six surveyed sleep difficulties were moderately frequent (~23%–46%), relatively mild, affected predominantly younger males, and considered a problem for 7%–20% of families. Snoring was more prevalent in older individuals. All sleep difficulties were associated with irritability/aggression and most also to hyperactivity. Only severe snoring was correlated with sleep apnea (loud snoring: 30%; sleep apnea: 2%–3%). Sleep difficulties are prevalent in children with FXS and, although they tend to be mild, they are associated with behavioral problems and negative impact to families. Because of its cross-sectional nature, clinic-origin, use of ad hoc data collection forms, and lack of treatment data, the present study should be considered foundational for future research aiming at better recognition and management of sleep problems in FXS. © 2021 Wiley Periodicals LLC.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort
    (2022)
    Budimirovic, Dejan B. (14420897100)
    ;
    Protic, Dragana D. (18635502600)
    ;
    Delahunty, Carol M. (26026204500)
    ;
    Andrews, Howard F. (7102091416)
    ;
    Choo, Tse-Hwei (56797933200)
    ;
    Xu, Qing (57370109600)
    ;
    Berry-Kravis, Elizabeth (7003985402)
    ;
    Kaufmann, Walter E. (57216064217)
    Fragile X syndrome (FXS), the leading cause of inherited intellectual disability and autism spectrum disorder, is associated with multiple neurobehavioral abnormalities including sleep difficulties. Nonetheless, frequency, severity, and consequences of sleep problems are still unclear. The Fragile X Online Registry with Accessible Research Database (FORWARD-version-3), including Clinician Report and Parent Report forms, was analyzed for frequency, severity, relationship with behavioral problems, and impact of sleep difficulties in a mainly pediatric cohort. A focused evaluation of sleep apnea was also conducted. Six surveyed sleep difficulties were moderately frequent (~23%–46%), relatively mild, affected predominantly younger males, and considered a problem for 7%–20% of families. Snoring was more prevalent in older individuals. All sleep difficulties were associated with irritability/aggression and most also to hyperactivity. Only severe snoring was correlated with sleep apnea (loud snoring: 30%; sleep apnea: 2%–3%). Sleep difficulties are prevalent in children with FXS and, although they tend to be mild, they are associated with behavioral problems and negative impact to families. Because of its cross-sectional nature, clinic-origin, use of ad hoc data collection forms, and lack of treatment data, the present study should be considered foundational for future research aiming at better recognition and management of sleep problems in FXS. © 2021 Wiley Periodicals LLC.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback